News About: Pharm. Industry
MR training booms in pharmaceutical circle
A number of employees at domestic pharmaceutical firms completed the medical representative (MR) training, which has been launched by the Korea Pharmaceutical Manufacturers Association in a bid to enhance the quality ...
Yuhan to launch functional health food business with new brand.Yuhan (President: Cha Joong-keun) announced to launch 2 new functional health food products into the market under the new brand "Willow", meaning the willow tree.
A company o...
|
GSK won patent dispute over ondansetron
The Seoul District Court ruled on October 30 that Asia Pharm's Zapron had violated the local patent of GlaxoSmithKline's ondansetron (brandname: Zofran) in a patent dispute filed by GSK Korea on March 2002, following ...
Government urged to sustain current tax break system for domestic technical transfer income
Following the recent move of Ministry of Finance and Economy to abolish the tax breaks of technical transfer income of domestic pharmaceutical makers in its tax revision, which has been submitted to the National Assem...
Small- and medium-sized firms advised to develop their own R&D strategies
Business sources say that except for a small number of large pharmaceutical firms, about 400 small- and medium-sized firms in Korea are facing fierce competition among makers with excessive number of me-too products b...
KFDA to cancel 9 product licenses of 5 companies
The KFDA announced to cancel the product registration for 9 products manufactured by 5 drug companies including Ahnam's cardiovascular drug due to poor qualities.
The product licence for Samick's herbal preparatio...
Amlodipine preparations likely to be flooded in the market.
Amlodipine preparation markets, an anti-hypertensive drug ranking the top prescription drug in Korea, may face with impending earthquakes by an explosive influx of too many copy products soon.
The market has been a...
Pfizer Korea's top-selling ethical products face strong challenge
Pharmaceutical business sources say that Pfizer Korea's flagship products such as Norvasc (amlodipine besylate) and Lipitor (atorvastatin) is/will be grapping with fierce competition among competitors to carve out the...
Yuhan Corporation targets pharmacy market
Yuhan Corporation, a leading pharmaceutical firm in Korea, is planning to implement "one-stop marketing" designed to supply a wide variety of OTC products to pharmacy via its existing outlets, as part of its efforts t...
KDRA: Drug discovery symposium
The Korea Drug Research Association (Chairman: Cho Ui-whan) plans to have the 3rd drug discovery symposium jointly with DI Biotech at Mariott hotel at 10 a.m. on Nov. 7 under the main theme of "Technology strategy in ...
